Brain Cellular Senescence as a Potential Mediator of Angiotensin II-Induced Hypertension
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BACKGROUND

METHODS

RESULTS

Elevated angiotensin II (Ang II) is a contributor to hypertension

Influence of CNS-specific cellular senescence on blood pressure
regulation

Ang II-induced hypertension is associated with changes in senescent
gene expression in the SFO, but not the OVLT or PVN.

• The etiology of hypertension is unknown in 95% of
cases. However, a subset of patients with
hypertension display elevated levels of Ang II
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(Carretero & Oparil Circulation, 2000; Catt et al. Br Med J,
1969).
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• Mice were also instrumented with intracerebroventricular
(ICV) cannulas.
• The senescence-inducing agent doxorubicin or vehicle
control was administered ICV daily over 3 days.

• Ang II induces oxidative stress, inflammation, and
endoplasmic reticulum (ER) stress in the CNS
during hypertension (Zimmerman et al. Circ Res, 2004;

• Following 3 days of ICV injections, ganglionic blockade was
performed via administration of chlorisondamine (12 mg/kg).

Marvar et al. Curr Opin Pharmacol, 2011; Young et al. J Clin
Invest, 2012).

Cellular senescence may be an integrative mechanism for Ang II-induced
hypertension
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• Adult C57Bl/6J male mice were implanted with
radiotelemeters for continuous blood pressure recordings in
conscious, freely moving mice.

• The hormone Ang II is a driver of hypertension
through sympathoexcitatory actions within the
central nervous system (CNS) (Reid Am J Physiol,
1992; Fisher & Paton J Hum Hypertens, 2012).
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Profiling of cellular senescence/SASP in CNS cardioregulatory nuclei
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• Oxidative stress, inflammation, and ER stress can lead to cellular senescence (Childs et al. Nat Med, 2015).
• Cellular senescence is a cell state characterized by prolonged and irreversible cell cycle arrest. While
commonly thought to occur in dividing cells, post-mitotic cells (e.g. neurons) can also undergo
senescence.

Real-time quantitative PCR analysis of the key senescent markers p16 (top) and p21 (bottom) in
micropunches of the SFO (left), OVLT (middle), and PVN (right) at baseline (Day 0) and following 14 days
of Ang II infusion. n=4-5/group. *p<0.05 vs Day 0.
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• Senescence results in the senescence-associated secretory phenotype (SASP), altered cellular
metabolism, and macromolecular damage.
• Cellular senescence contributes to conditions that are closely associated with hypertension, including
aging and neurodegenerative diseases (Kritsilis et al. Int J Mol Sci, 2018; Sikora et al. Curr Vasc Pharmacol, 2014).

Removal of senescent cells prevents Ang II-induced hypertension

Ang II-induced hypertension is paralleled by the upregulation of SASP
markers in the SFO.
• Adult C57Bl/6J male mice were implanted with subcutaneous mini-osmotic pumps for continuous
infusion of Ang II (600 ng/kg/min). Brains were collected at baseline (day 0) and following 14-day Ang II
infusion.
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• Micropunches of cardiovascular/autonomic regulatory nuclei including the subfornical organ (SFO),
organum vasculosum lamina terminalis (OVLT), and paraventricular nucleus of the hypothalamus
(PVN) were collected for quantitative real-time PCR.

RESULTS
Adult p16INK4a-ATTAC males

Baker et al. Nature, 2011

Induction of CNS senescence results in a hypertensive phenotype
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Real-time quantitative PCR analysis of the SASP markers (A) IL1-alpha, (B) IL-8, and (C) MCP1 in
micropunches of the SFO at baseline (Day 0) and following 14 days of Ang II infusion. n=4-5/group.
*p<0.05 vs Day 0.

n=3-4. *p<0.05 group x time interaction.

• The transgenic INK-ATTAC mouse model allows for selective elimination of senescent cells with the
drug AP20187, which induces the dimerization of a caspase 8 fusion protein to drive apoptosis in
senescent cells expressing p16 (Baker et al. Nature, 2011).
• Adult p16INK4a-ATTAC male mice were implanted with subcutaneous mini-osmotic pumps for continuous
infusion of Ang II (600 ng/kg/min). Additionally, mice received daily injections of the activating drug
AP20187 or vehicle control.
• Removal of senescent cells prevented hypertension development. However, it is unclear where
senescent cells are accumulating.

HYPOTHESIS
CNS cellular senescence is a novel contributor to hypertension.

A)
Mean
arterial
blood
pressure during 3-day ICV
injection of the senescence
inducing agent doxorubicin
(0.00125mg/kg/day) or vehicle
control (αCSF). B) Change in
mean arterial blood pressure
following ganglionic blockade
with
chlorisondamine
(12
mg/kg). n=3/group. *p<0.05 vs
ICV vehicle.

CONCLUSIONS
1) Acute induction of cellular senescence selectively in the CNS results in
elevations in arterial blood pressure.
2) Ang II elicits cellular senescence/SASP in the SFO, but not in other
cardioregulatory nuclei including the PVN and OVLT.
Collectively, these data may point to brain cellular senescence as a novel
mediator of hypertension.
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